
Adults with AChR antibody–positive generalized myasthenia gravis now have a C5 inhibitor they can inject themselves at home once a week.
Top articles of 2016 on Specialty Pharmacy Times.
[<a href="//storify.com/pharmacytimes/the-year-in-biosimilars" target="_blank">View the story "The Year in Biosimilars" on Storify</a>]




